Allt inom Regulatory
Nanexa publishes interim report for January-September 2025
We have progressed with the optimization of our GLP-1 formulations, extended an existing commercial partnership, received approval for a PharmaShell patent application in Japan and submitted three new patent applications.
Nanexa AB changes Certified Adviser to Tapper Partners AB
Nanexa AB announces today that the company is changing its Certified Adviser to Tapper Partners AB.